HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 288 filers reported holding HORIZON PHARMA PLC in Q1 2019. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $26,731,000 | +38.6% | 1,011,369 | +2.5% | 0.04% | +29.4% |
| Q4 2018 | $19,285,000 | -9.2% | 986,967 | -9.1% | 0.03% | +9.7% |
| Q3 2018 | $21,249,000 | +11.9% | 1,085,206 | -5.4% | 0.03% | +10.7% |
| Q2 2018 | $18,993,000 | +382.4% | 1,146,890 | +313.7% | 0.03% | +366.7% |
| Q1 2018 | $3,937,000 | +256.0% | 277,244 | +265.8% | 0.01% | +200.0% |
| Q4 2017 | $1,106,000 | +12.7% | 75,800 | -2.1% | 0.00% | +100.0% |
| Q3 2017 | $981,000 | +371.6% | 77,390 | +342.0% | 0.00% | – |
| Q2 2017 | $208,000 | -15.8% | 17,510 | +5.0% | 0.00% | – |
| Q1 2017 | $247,000 | -6.1% | 16,680 | +2.6% | 0.00% | – |
| Q4 2016 | $263,000 | -42.7% | 16,260 | -35.8% | 0.00% | -100.0% |
| Q3 2016 | $459,000 | +92.1% | 25,344 | +74.8% | 0.00% | – |
| Q2 2016 | $239,000 | +2.1% | 14,500 | +60.7% | 0.00% | – |
| Q1 2015 | $234,000 | – | 9,021 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scale Management, LLC | 1,710,451 | $37,065,000 | 56.74% |
| Broadfin Capital, LLC | 8,131,310 | $176,205,000 | 10.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,684,801 | $253,210,000 | 10.26% |
| ATERNALIS CAPITAL LLC | 410,000 | $8,885,000 | 5.84% |
| JW Asset Management, LLC | 673,075 | $14,586,000 | 5.44% |
| NEXTHERA CAPITAL LP | 144,000 | $3,120,000 | 4.43% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 739,485 | $16,025,000 | 2.77% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,519,955 | $54,607,000 | 2.66% |
| Ratan Capital Management LP | 500,000 | $10,835,000 | 2.39% |
| TIGER MANAGEMENT L.L.C. | 823,577 | $17,847,000 | 2.30% |